Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Methylprednisolone Pulse Treatment of Graves´Ophthalmopathy is not associated with secondary Adrenocortical insufficiency

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk of Thyroid Cancer in 1,504 Patients Referred for Thyroid Surgery with Assumed Benign Histology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Previous Live Births and Induced Abortions May Precede Later Development of Graves' Hyperthyroidism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Predictors of Improvement in Quality of Life When Treating Hypothyroidism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Influence of educational level on test and treatment for incident hypothyroidism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The influence of substitution therapy with levothyroxine for hypothyroidism on physiological mechanisms determining body weight

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

Vis graf over relationer
Objective: Graves' ophthalmopathy (GO) is an inflammatory disease in the orbital region. The first-line medical treatment is glucocorticoids. An important potential side effect of glucocorticoid treatment is suppression of the hypothalamic-pituitary-adrenal (HPA) axis with impairment of endogenous cortisol production, implicating symptoms of adrenocortical insufficiency, especially in the period after cessation of therapy with possible risks in cases of intercurrent illness. The aim of this study was to evaluate HPA axis function before and after methylprednisolone pulse treatment of GO. Study Design: HPA axis function was evaluated by measurements of plasma ACTH and an ACTH stimulation test with plasma cortisol measurements at 0 and 30 min after an intravenous bolus of synthetic ACTH (Synacthen® 250 µg). This was done in 12 patients with GO before and at cessation of methylprednisolone pulse treatment (500 mg i.v. per week for 6 weeks followed by 250 mg i.v. per week for an additional 6 weeks). Results: All patients included fulfilled the criteria of intact HPA axis function before and at cessation of methylprednisolone pulse treatment. Data are given as medians (with ranges). Before glucocorticoid treatment basal plasma cortisol was 290 nM (196-579) and 786 nM (612-1,050) after ACTH stimulation. At cessation of therapy the corresponding values were 309 nM (88-718) and 852 nM (524-1,011), respectively. Thus, all patients passed a 30-min stimulated plasma cortisol of 500 nM. Before treatment plasma ACTH was 4.2 pmol/l (4-16) and at cessation of therapy the corresponding value was 4.8 pmol/l (2-9; p = 0.27). Conclusion: Transient suppression of the HPA axis with secondary adrenocortical insufficiency does not seem to be a common phenomenon after intravenous methylprednisolone pulse therapy for GO. Therefore, routine precautions are not necessary. However, our results do not exclude that transient secondary adrenocortical insufficiency might occur occasionally.

© 2015 European Thyroid Association Published by S. Karger AG, Basel
OriginalsprogEngelsk
TidsskriftEuropean Thyroid Journal
Vol/bind4
Udgave nummer4
Sider (fra-til)222-225
Antal sider4
ISSN2235-0640
DOI
StatusUdgivet - 2015

ID: 46025337